12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks showed significant movement in Friday's pre-market session. RVL Pharmaceuticals, Vaccinex, T2 Biosystems, Akso Health Group, Exagen, and Bone Biologics saw gains, while Freeline Therapeutics, Nanobiotix, Longeveron, Vivos Therapeutics, BioCardia, and Koninklijke Philips experienced losses.
October 06, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group stock rose 9.56% to $1.26.
The significant rise in Akso Health Group's stock price suggests strong investor interest, potentially driving further short-term increases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Bone Biologics shares increased by 8.58% to $0.62.
The substantial increase in Bone Biologics' share price indicates positive investor sentiment, which could lead to additional short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
RVL Pharmaceuticals shares rose 19.5% to $0.13 during Friday's pre-market session.
The significant increase in RVL Pharmaceuticals' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems shares increased by 14.4% to $0.22.
The substantial increase in T2 Biosystems' share price indicates positive investor sentiment, which could lead to additional short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Vaccinex shares moved upwards by 19.49% to $0.98.
The sharp rise in Vaccinex's share price suggests strong investor interest, potentially driving further short-term increases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Exagen shares moved upwards by 8.69% to $2.25.
The sharp rise in Exagen's share price suggests strong investor interest, potentially driving further short-term increases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
BioCardia stock decreased by 11.73% to $0.34.
The sharp decline in BioCardia's stock price suggests weak investor interest, potentially driving further short-term decreases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Freeline Therapeutics shares fell 14.8% to $2.81 during Friday's pre-market session.
The significant decrease in Freeline Therapeutics' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Longeveron stock decreased by 12.45% to $1.83.
The substantial decrease in Longeveron's stock price indicates negative investor sentiment, which could lead to additional short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Nanobiotix shares decreased by 13.77% to $6.64.
The sharp decline in Nanobiotix's share price suggests weak investor interest, potentially driving further short-term decreases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Koninklijke Philips shares declined by 10.2% to $17.7.
The substantial decrease in Koninklijke Philips' share price indicates negative investor sentiment, which could lead to additional short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Vivos Therapeutics shares fell 12.14% to $0.29.
The significant decrease in Vivos Therapeutics' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100